WINT : Insider Transactions for Windtree Therapeutics Inc

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

New Search

Get Insiders for :

Windtree Therapeutics Inc (WINT)

$0.16 0.00 (0.00%) as of 4:30 Thu 2/23

Download

Exchange:

Nasdaq National Market

Security Type:

Common

Shares Out:

16,920,000

Market Cap:

2.77(M)

Last Volume:

25,688,722

Avg Vol:

24,206,070

52 Week Range:

$0.164 - $0.164

Level I Sector:

Health Care

Level II Sector:

Drugs

Level III Sector:

Biotechnology

Member Indexes:

	NASDAQ BIOTECHNOLOGY		NASDAQ COMPOSITE
	NASDAQ NNM COMPOSITE

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile Windtree Therapeutics is a clinical-stage, biopharmaceutical company focused on the development of therapeutics to address unmet medical needs in acute care markets. Co.'s primary product candidate, istaroxime, is a dual-acting agent being developed to improve cardiac function in patients with acute heart failure. In addition, Co. cardiovascular drug product candidates include rostafuroxin, for the treatment of hypertension in patients with a specific genetic profile. Co.'s pulmonary product candidate portfolio consists of a KL4 surfactant platform to address a range of serious respiratory conditions in children and adults.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	2,500	24,812
Total Buy Value	$0	$0	$2,250	$15,204
Total People Bought	0	0	1	2
Total Buy Transactions	0	0	1	8
Total Shares Sold	0	0	0	0
Total Sell Value	$0	$0	$0	$0
Total People Sold	0	0	0	0
Total Sell Transactions	0	0	0	0
End Date	2024-02-08	2023-11-07	2023-05-09	2022-05-09

Adjust Filter Settings

Records found: 619

Page 8 of 25

Filer's Name

Relation Title

Off-Dir-10%

Tran. Date

Form

Action

Price

Mkt Value

D/I

Shares

Holdings

Rank

3m +/-

Form

Tattory John Andrew

SVP & Chief Financial Officer

• – –

2014-06-30

$1.78

$3,900

I/I

2,191

34,629

Cooper John G

President & CEO

• • –

2014-06-30

$1.78

$4,375

I/I

2,458

39,711

Mahady Joseph M

Director

– • –

2014-06-18

$0.00

D/D

4,678

9,412

Leone John R

Director

– • –

2014-06-18

$0.00

D/D

22,222

29,956

Rosenthale Marvin E

Director

– • –

2014-06-18

$0.00

D/D

4,678

9,412

Peacock Bruce

Director

– • –

2014-06-18

$0.00

D/D

4,678

9,412

Magee Michael L

VP, Quality Operations

• – –

2014-03-31

$2.15

$4,375

I/I

2,035

31,388

Cole Kathy

Senior VP, Human Resources

• – –

2014-03-31

$2.15

$4,373

I/I

2,034

39,419

Hoy Thomas

VP, Manufacturing Ops.

• – –

2014-03-31

$2.15

$4,375

I/I

2,035

36,212

Miller Thomas F

SVP, Chief Operating Officer

• – –

2014-03-31

$2.15

$4,375

I/I

2,035

39,540

Templeton Mary B Esq

SVP, Gen Counsel & Corp Sec

• – –

2014-03-31

$2.15

$4,218

I/I

1,962

38,730

Tattory John Andrew

SVP & Chief Financial Officer

• – –

2014-03-31

$2.15

$3,900

I/I

1,814

34,629

Cooper John G

President & CEO

• • –

2014-03-31

$2.15

$4,375

I/I

2,035

39,711

Magee Michael L

VP, Quality Operations

• – –

2013-12-31

5/A

$2.23

$4,375

I/I

1,962

20,580

Cooper John G

President, CEO, & CFO

• – –

2013-12-31

$2.23

$4,375

I/I

1,962

28,903

Templeton Mary B Esq

SVP, Gen Counsel, & Corp Sec

• – –

2013-12-31

$2.23

$4,126

I/I

1,850

27,860

Miller Thomas F

Senior VP & COO

• – –

2013-12-31

$2.23

$4,375

I/I

1,962

28,732

Cole Kathy

Senior VP, Human Resources

• – –

2013-12-31

$2.23

$4,375

I/I

1,962

28,611

Hoy Thomas

VP, Manufacturing Ops.

• – –

2013-12-31

$2.23

$4,375

I/I

1,962

25,404

Tattory John Andrew

VP, Finance & CAO

• – –

2013-12-31

$2.23

$3,900

I/I

1,749

24,994

Clayton Russell

Senior VP, R&D

• – –

2013-12-31

$2.23

$4,375

I/I

1,962

18,854

Cooper John G

President, CEO, & CFO

• – –

2013-09-30

$1.73

$4,375

I/I

2,529

28,903

Templeton Mary B Esq

SVP, Gen Counsel, & Corp Sec

• – –

2013-09-30

$1.73

$4,124

I/I

2,384

27,860

Miller Thomas F

Senior VP & COO

• – –

2013-09-30

$1.73

$4,375

I/I

2,529

28,732

Cole Kathy

Senior VP, Human Resources

• – –

2013-09-30

$1.73

$4,375

I/I

2,529

28,611

619 Records found	1 2 3 4 5 6 7 8 9 Next	Page 8 of 25

Transaction Code Key:				Ownership Code Key
B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
OE	- Options Exercised	A	- Acquired
IO	- Initital Ownership	D	- Disposed

Summary:

Chart:

3m +/-: